You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Deconstructing COVID-19 Vaccine Hesitancy: Providing Tailored Solutions Across the Spectrum

  • Authors: Miriam Taegtmeyer, BM BCh, FRCP, PhD; Rupali J. Limaye, PhD, MPH, MA; Barbara A. Rath, MD, PhD, HDR
  • CPD Released: 2/11/2022
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 2/11/2023, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This educational activity is intended for a non-US audience of primary care physicians, infectious disease specialists, and pediatricians.

The goal of this activity is to educate clinicians on vaccine hesitancy and perspective-driven concerns surrounding vaccination, and on the available strategies to address these concerns.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Vaccination uptake across European countries
    • Definitions of vaccine hesitancy
    • Strategies for overcoming vaccine hesitancy


Disclosures

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.


Faculty

  • Miriam Taegtmeyer, BM BCh, FRCP, PhD

    Professor of Global Health
    Liverpool School of Tropical Medicine
    Liverpool, United Kingdom

    Disclosures

    Grants for clinical research from: Unilever

  • Rupali J. Limaye, PhD, MPH, MA

    Director of Behavioral and Implementation Science
    International Vaccine Access Center
    Johns Hopkins Bloomberg School of Public Health
    Baltimore, Maryland, United States

    Disclosures

    No relevant financial relationships

  • Barbara A. Rath, MD, PhD, HDR

    Co-founder & Chair
    Vienna Vaccine Safety Initiative
    USA/Germany
    Research Director
    University of Bourgogne Franche-Comte,
    Besançon, France

    Disclosures

    Advisor or consultant for: AstraZeneca; Atriva; GlaxoSmithKline; Roche

Steering Committee Members

  • Paolo Bonanni, MD

    Professor of Hygiene​
    Faculty of Medicine​
    Director​
    Department of Health Sciences​
    University of Florence​
    Florence, Italy

    Disclosures

    Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; GlaxoSmithKline; Janssen Pharmaceuticals; Merck Sharp & Dohme Corp; Pfizer Inc.; Sanofi Pasteur; Seqirus
    Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals, LP; GlaxoSmithKline; Janssen Pharmaceuticals; Merck Sharp & Dohme Corp; Pfizer Inc.; Sanofi Pasteur; Seqirus
    Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; GlaxoSmithKline; Merck Sharp & Dohme Corp; Pfizer Inc.; Sanofi Pasteur; Seqirus

  • Federico Martinón-Torres, MD, PhD

    Head of Pediatrics
    Director of Translational Pediatrics and Infectious Diseases
    Hospital Clínico Universitario de Santiago
    Associate Professor in Pediatrics
    University of Santiago de Compostela
    Galicia, Spain

    Disclosures

    Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Biofabri; GlaxoSmithKline; Janssen Pharmaceuticals; Merck & Co., Inc.; Moderna; Novavax; Pfizer Inc.; Roche; Sanofi Pasteur
    Served as a speaker or a member of a speakers bureau for:  AstraZeneca Pharmaceuticals LP; GlaxoSmithKline; Janssen Pharmaceuticals; Merck & Co., Inc.; Moderna; Pfizer Inc.; Sanofi Pasteur
    Received grants for clinical research from: Ablynx; Astra-Zeneca; Biofabri; Cubist; Janssen Pharmaceuticals; GlaxoSmithKline; Merck & Co., Inc.; Moderna; Novavax; Pfizer Inc.; Regeneron; Roche; Sanofi Pasteur

  • George Kassianos, CBE, MD (Hons), FRCGP

    General Practitioner, National Immunization Lead
    Royal College of General Practitioners
    President, British Global and Travel Health Association
    London, United Kingdom

    Disclosures

    No relevant financial relationships

  • Ravindra Gupta, MD, PhD

    Professor of Clinical Microbiology
    Cambridge Institute of Therapeutic Immunology & Infectious Disease
    University of Cambridge
    Cambridge, United Kingdom

    Disclosures

    Served as an advisor or consultant for: GlaxoSmithKline; ViiV Healthcare
    Served as a speaker or a member of a speakers bureau for: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Received grants for clinical research from: Wellcome

  • Karine Lacombe, MD, PhD

    Professor of Infectious Diseases 
    Sorbonne University  
    Head of Infectious and Tropical Diseases Department 
    Saint-Antoine Hospital 
    Inserm, Institut Pierre Louis de Santé Publique 
    Paris, France 

    Disclosures

    Served as an advisor or consultant for: Chiesi Pharmaceuticals; GlaxoSmithKline; Merck; Sobi; SpikImm

  • Saul N. Faust, FRCPCH, PhD

    Professor of Paediatric Immunology and Infectious Diseases 
    Director 
    NIHR Southampton Clinical Research Facility 
    University Hospital Southampton NHS Foundation Trust  
    and University of Southampton 
    Southampton, United Kingdom 

    Disclosures

    Served as an advisor or consultant for: GlaxoSmithKline; Johnson & Johnson; Merck; Pfizer; Sanofi; Seqirus
    Served as a speaker or a member of a speakers bureau for: Johnson & Johnson; Pfizer
    Received grants for clinical research from: AstraZeneca; GlaxoSmithKline; Johnson & Johnson; Merck; Pfizer; Sanofi; Valneva

  • Philip Haaf, MD

    Department of Cardiology
    Cardiovascular Research Institute Basel
    University Hospital Basel
    Basel, Switzerland

    Disclosures

    No relevant financial relationships

Editors

  • Alessia Piazza, PhD

    Medical Education Director, WebMD Global, LLC 

    Disclosures

    Disclosure: Alessia Piazza, PhD, has disclosed no relevant financial relationships.  

  • Diana Lucifero, PhD

    Scientific Content Manager, WebMD Global, LLC 

    Disclosures

    Disclosure: Diana Lucifero, PhD, has disclosed no relevant financial relationships.  

Compliance Reviewer

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC 

    Disclosures

    Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Deconstructing COVID-19 Vaccine Hesitancy: Providing Tailored Solutions Across the Spectrum

Authors: Miriam Taegtmeyer, BM BCh, FRCP, PhD; Rupali J. Limaye, PhD, MPH, MA; Barbara A. Rath, MD, PhD, HDRFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CPD Released: 2/11/2022

Valid for credit through: 2/11/2023, 11:59 PM EST

processing....

Trascrizione in italiano

Download the pdf.

« Return to: Deconstructing COVID-19 Vaccine Hesitancy: Providing Tailored Solutions Across the Spectrum
  • Print